Delivery Order SPE2DB25D3108-SPE2DB26FPBJS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with a ceiling value of $3,417.46. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Icosapent Ethyl 1 Gram Capsules in quantities of 120 units, with a ceiling value of $2,212.37. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule (120-count packages) with a ceiling value of $1,779.42. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 1, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with a ceiling value of $1,118.97. This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 120 capsules of Icosapent Ethyl 1 gram pharmaceutical product, valued at $1,250.91. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of June 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a task under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Icosapent Ethyl 1 Gram Capsule (120-count bottles) with a ceiling value of $3,471.13. This is a firm fixed-price delivery order with no set-aside designation, utilizing open competitive procurement. The contract is scheduled for ultimate completion on May 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,871.58 firm fixed-price delivery order is for the supply of 120-count capsules of the drug Icosapent Ethyl 1 gram. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- The Defense Logistics Agency awarded a delivery order valued at $452,250 to Amerisourcebergen Drug Corporation for the provision of 120 capsules of 1 gram Icosapent Ethyl capsules. This firm fixed price order is being carried out under the Prime Vendor Program, with performance taking place in Conshohocken, Pennsylvania from August 18-21, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply chain for the United States...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $5,154 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 120 capsules of 1 gram Icosapent Ethyl capsules to be delivered to a location in Conshohocken, Pennsylvania by August 14, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports Department of Defense health care programs and maintains medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.04 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB26FPBJSDelivery Order
This delivery order, valued at $2,322.47, was awarded to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with an ultimate completion date of October 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The Defense Logistics Agency, which serves the Department of Defense's medical supply chain requirements, is the funding federal agency, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. This prime indefinite delivery vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally, enabling the company to fulfill diverse medical procurement needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current delivery order represents a routine pharmaceutical fulfillment within this expansive contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 10/21/25 |